Literature DB >> 5777357

Optic atrophy during chlorpromazine therapy.

S M Rab, M N Alam, M D Sadequzzaman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5777357      PMCID: PMC1207177          DOI: 10.1136/bjo.53.3.208

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

1.  DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.

Authors:  P E FELDMAN; B D FRIERSON
Journal:  Am J Psychiatry       Date:  1964-08       Impact factor: 18.112

2.  A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE.

Authors:  A S ZELICKSON; H C ZELLER
Journal:  JAMA       Date:  1964-04-27       Impact factor: 56.272

3.  Ocular melanosis with special reference to chlorpromazine.

Authors:  M E Cameron
Journal:  Br J Ophthalmol       Date:  1967-05       Impact factor: 4.638

4.  Eye and skin changes in psychiatric patients treated with chlorpromazine.

Authors:  M B Mathalone
Journal:  Br J Ophthalmol       Date:  1967-02       Impact factor: 4.638

  4 in total
  1 in total

1.  Toxic effects of phenothiazines on the eye.

Authors:  D J Boet
Journal:  Doc Ophthalmol       Date:  1970-07-24       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.